Lori Ann Isely, AUDIOLOGIST | |
1200 E Pecan, Altus, OK 73521 | |
(580) 482-4781 | |
(580) 481-2345 |
Full Name | Lori Ann Isely |
---|---|
Gender | Female |
Speciality | Audiologist |
Location | 1200 E Pecan, Altus, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518990225 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | 338 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lori Ann Isely, AUDIOLOGIST 1200 E Pecan, Po Box 8190, Altus, OK 73522-8190 Ph: (580) 482-4781 | Lori Ann Isely, AUDIOLOGIST 1200 E Pecan, Altus, OK 73521 Ph: (580) 482-4781 |
News Archive
DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), supports dialysis patients' education by offering individualized treatment options based on optimal patient care standards and social circumstances.
Scientists are trying to open a new front in the battle against gum disease, the leading cause of tooth loss in adults and sometimes termed the most serious oral health problem of the 21st century. They described another treatment approach for the condition in a report here today at the 244th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.
While recent reports question whether fish oil supplements support heart health, UC Irvine scientists have found that the fatty acids they contain are vitally important to the developing brain.
By 2017, the global electrophysiology mapping and ablation devices market is likely to achieve a value of $2.1 billion, according to a new report on companiesandmarkets.com. An ageing population, an increased number of diagnoses and several clinical studies have encouraged market growth.
An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML)
› Verified 2 days ago